Frontotemporal dementia prevalence

Addressing The Scattered Harbingers of Frontotemporal Dementia

  • by

The present Frontotemporal dementia market comprises of symptomatic medications since no therapy has been approved to help affected patients. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipeline. One… Read More »Addressing The Scattered Harbingers of Frontotemporal Dementia